首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1547538

全球更年期潮熱市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Menopausal Hot Flashes Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球更年期潮熱市場需求預計將從 2023 年的 411.7 億美元達到近 657.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.34%。

潮熱是更年期併發症最常見的血管舒縮症狀。一般症狀包括突然感到強烈的溫暖感遍布全身並持續幾分鐘，導致出汗、潮紅和心悸。這可能發生在白天或晚上。潮熱的強度因女性而異，取決於許多生理化學因素。它可能是輕度、中度、重度和使人衰弱的。荷爾蒙替代療法被認為是治療更年期潮熱的黃金標準。然而，長期荷爾蒙替代療法會增加乳癌的風險以及與年齡成長相關的風險，例如中風、血栓和其他健康相關問題。其他療法包括服用維生素 E 補充劑和抗憂鬱藥物以及許多補充療法。在美國和其他已開發地區，大約70%的更年期女性患有永續數年的潮熱症狀。

市場動態

推動該市場成長的重要因素是更年期症狀治療的需求不斷成長，因為女性在此期間會經歷精神和身體的變化。此外，失眠、煩躁、情緒波動、疲勞、焦慮、偏頭痛、排蟻和潮熱等症狀的顯著增加也推動了對更年期症狀藥物的需求。除了藥物治療外，知名人士還建議女性採用尖端技術設備，例如具有個人恆溫器的類似智慧手錶的設備。然而，解決更年期潮熱問題的重要認知行為療法也推動了市場的成長。對非藥物治療的需求不斷成長預計將推動此類療法在全球更年期潮熱市場的成長。然而，女性對更年期潮熱的認知不斷提高，將進一步推動預測期內全球更年期潮熱市場的成長。除口服藥物外，許多治療方案的出現也促進了全球更年期潮熱市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球更年期潮熱市場的各個細分市場進行了包容性評估。更年期潮熱產業的成長和趨勢為本研究提供了整體方法。

市場區隔

更年期潮熱市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按治療類型

荷爾蒙治療
非荷爾蒙治療
替代治療

按配銷通路

醫院藥房
零售藥局
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲更年期潮熱市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。更年期潮熱市場的主要參與者包括輝瑞公司、諾華公司、諾和諾德、艾爾建公司、梯瓦製藥工業有限公司、Mylan NV、久光製藥有限公司、默克公司、葛蘭素史克公司，TherapeuticsMD Inc. 本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：更年期潮熱公司的競爭格局

更年期潮熱市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Pfizer Inc.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Novo Nordisk A/S

公司概況
公司收入
產品
最新動態

Allergan Plc

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Ltd

公司概況
公司收入
產品
最新動態

Mylan NV

公司概況
公司收入
產品
最新動態

Hisamitsu Pharmaceutical Co. Inc.

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

TherapeuticsMD Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215024

The global demand for Menopausal Hot Flashes Market is presumed to reach the market size of nearly USD 65.75 Billion by 2032 from USD 41.17 Billion in 2023 with a CAGR of 5.34% under the study period 2024-2032.

Hot flashes are the most usual vasomotor symptom of menopause complications. The general symptoms include a sudden sensation of intense warmth spreading over the body and lasting for several minutes, leading to sweat, red flush, and palpitations. This may occur during the day or at night. The intensity of hot flashes varies from woman to woman depending on many physiochemical factors. It may be mild, moderate, and severe, and debilitating. Hormone replacement therapy has been considered the gold standard for treating menopausal hot flashes. However, long-term HRT has an increased risk of breast cancer and risk associated with increasing age, such as stroke, blood clots, and other health-related problems. Other therapies include intake of vitamin E supplements and anti-depressants along with many complementary therapies. In the U.S. and other developed regions, about 70% of menopausal women suffer from hot flashes that can last for several years.

MARKET DYNAMICS

The significant factor driving the growth of this market is the rising need of treatment for menopause symptoms as women go through mental and physical changes during this. In addition, a significant spike in insomnia, irritability, mood swings, fatigue, anxiety, migraine, formication, and hot flashes also propels the demand for menopause symptom medication. Apart from medication, the prominent players are counseling women to adopt edge-cutting technological devices such as smartwatch-like devices which have a personal thermostat. However, a significant cognitive behavior therapies to address the menopausal hot flash issues also drives the growth of the market. The growing demand for non-pharmacological treatment is expected to propel the growth of such therapies in the global menopausal hot flashes market. However, the increasing awareness among women regarding menopausal hot flashes will further drive the global menopausal hot flashes market's growth during the forecast period. The availability of many treatment options other than oral medications has also boosted the growth of the global menopausal hot flashes market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Menopausal Hot Flashes. The growth and trends of Menopausal Hot Flashes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Menopausal Hot Flashes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Hormonal Treatment
Non-hormonal Treatment
Alternative Treatment

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Menopausal Hot Flashes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Menopausal Hot Flashes market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan Plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline Plc, TherapeuticsMD Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MENOPAUSAL HOT FLASHES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY TREATMENT TYPE

5.1. Overview By Treatment Type
5.2. Historical and Forecast Data Analysis By Treatment Type
5.3. Hormonal Treatment Historic and Forecast Sales By Regions
5.4. Non-hormonal Treatment Historic and Forecast Sales By Regions
5.5. Alternative Treatment Historic and Forecast Sales By Regions

6. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
6.4. Retail Pharmacies Historic and Forecast Sales By Regions
6.5. Online Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL MENOPAUSAL HOT FLASHES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MENOPAUSAL HOT FLASHES COMPANIES

8.1. Menopausal Hot Flashes Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MENOPAUSAL HOT FLASHES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Pfizer Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Novartis AG
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Novo Nordisk A/S
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Allergan Plc
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Teva Pharmaceutical Industries Ltd
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Mylan N.V.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Hisamitsu Pharmaceutical Co. Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Merck & Co. Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. GlaxoSmithKline Plc
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. TherapeuticsMD Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments